"NOVA - 'Addiction'"
The work and expertise of Yasmin Hurd, PhD, the Ward-Coleman chair of translational neuroscience and director of the Addiction Institute of Mount Sinai, and Rita Goldstein, PhD, professor of psychiatry and neuroscience, and director of the Neuropsychoimaging of Addiction and Related Conditions Research group at the Icahn School of Medicine at Mount Sinai, was featured on NOVA, the most-watched prime time science series on American television. Scientists are studying why addiction is not a moral failing, but a chronic treatable medical condition. Easy access to drugs like heroin, fentanyl, and prescription medications like OxyContin, has fueled an epidemic of addiction—the deadliest in U.S. history. Now, science is revealing how addiction affects the brain, and top experts are gathering evidence about how we should address the nation’s drug problem, from embracing evidence-based treatments to rethinking public policies.
- Yasmin Hurd, PhD, Professor, Psychiatry, Neuroscience, Pharmacology, Systems Therapeutics, Icahn School of Medicine at Mount Sinai, Chair, Ward-Coleman Translational Neuroscience, Director of the Center for Addictive Disorders, Mount Sinai Health System
- Rita Goldstein, PhD, Professor, Psychiatry, Neuroscience, Icahn School of Medicine at Mount Sinai, Chief, Brain Imaging Core, Director, Neuropsychoimaging of Addiction and Related Conditions Research Program of Mount Sinai
